On 2026-03-05, Evommune Inc. (EVMN) announced earnings per share of $-1.43 for the fiscal quarter ending 2025-12-31, missing the average analyst estimate of $-0.82.

The next expected annoucement date for quarterly earnings is 2026-06-04, with an average estimated earnings per share of $-0.72 for the fiscal quarter ending 2026-03-31.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.